財信發展(000838.SZ):攜上海泰生成立財信泰生 共同在上海地區尋找項目
格隆匯5月22日丨財信發展(000838.SZ)公佈,根據公司業務發展需要,公司的全資子公司連雲港財信公司擬與上海泰生公司共同出資設立上海財信泰生投資發展有限公司,註冊資本為人民幣1000萬元。連雲港財信公司以自有貨幣資金出資900萬元,佔註冊資本的90%;上海泰生公司以自有貨幣資金出資100萬元,佔註冊資本的10%。財信泰生公司將納入公司合併報表範圍。
上海泰生公司經營範圍包括醫療科技、生物科技領域內的技術開發、技術諮詢、技術服務、技術轉讓、一類醫療器械、二類醫療器械的批發、零售、三類醫療器械經營等。
公司表示,此次連雲港財信公司與上海泰生公司共同出資設立財信泰生公司,是為了結合各方資源與房地產開發經驗,共同在上海地區尋找併力求獲取項目,實現公司可持續發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.